Yoshiaki Matsumoto Selected Research

Yoshiaki Matsumoto Research Topics

Disease

9	Neoplasms (Cancer) 07/2021 - 11/2005
6	Breast Neoplasms (Breast Cancer) 08/2021 - 12/2015
4	Body Weight (Weight, Body) 05/2014 - 06/2006
3	Stomach Neoplasms (Stomach Cancer) 05/2009 - 01/2008
2	Cicatrix (Scar) 01/2015 - 10/2011
2	Hypertrophic Cicatrix (Hypertrophic Scar) 01/2015 - 10/2011
2	Chronic Renal Insufficiency 01/2014 - 01/2014
2	Hyperplasia 03/2009 - 07/2008
2	Critical Illness (Critically Ill) 05/2007 - 09/2003
2	Tremor (Tremors) 02/2007 - 01/2006
2	Memory Disorders (Memory Loss) 02/2007 - 01/2006
2	Colitis 02/2006 - 01/2002
1	Stroke (Strokes) 12/2020
1	Intellectual Disability (Idiocy) 12/2020
1	Disease Progression 06/2020
1	Neoplasm Metastasis (Metastasis) 06/2020
1	Mycoplasma Pneumonia 04/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015
1	Liver Diseases (Liver Disease) 01/2015
1	Burns 01/2015
1	Heart Failure 01/2014
1	Weight Loss (Weight Reduction) 01/2014
1	Obesity 01/2014
1	Hyperlipidemias (Hyperlipidemia) 01/2014
1	Hyperuricemia 01/2014
1	Hemorrhage 01/2012
1	Lupus Nephritis 01/2012
1	Keloid 10/2011
1	Sarcoma (Soft Tissue Sarcoma) 07/2011
1	Colorectal Neoplasms (Colorectal Cancer) 07/2011
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 07/2011
1	Fibrosis (Cirrhosis) 01/2011
1	Nephrosclerosis 01/2011
1	Gastroesophageal Reflux (GERD) 05/2009
1	Peptic Esophagitis (Reflux Esophagitis) 05/2009
1	Atrophic Gastritis 05/2009
1	Stomach Ulcer (Gastric Ulcer) 05/2009
1	Ulcer 05/2009
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2009
1	Neointima 03/2009

Drug/Important Bio-Agent (IBA)

8	Nylons (Nylon)IBA 01/2015 - 07/2008
6	Pharmaceutical PreparationsIBA 12/2015 - 10/2005
3	Fluorouracil (Carac)FDA LinkGeneric 06/2020 - 11/2005
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2008
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2015 - 01/2011
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2018
2	imidazoleIBA 01/2015 - 10/2011
2	PyrrolesIBA 01/2015 - 10/2011
2	PrebioticsIBA 07/2011 - 01/2002
2	Messenger RNA (mRNA)IBA 07/2011 - 07/2008
2	AcidsIBA 05/2009 - 02/2006
2	Vancomycin FDA LinkGeneric 01/2008 - 01/2002
2	Antifungal AgentsIBA 05/2007 - 12/2005
2	OxotremorineIBA 02/2007 - 01/2006
2	Butyrates (Butyrate)IBA 02/2006 - 01/2002
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 02/2006 - 01/2002
2	Dextrans (Dextran)FDA Link 02/2006 - 01/2002
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2020
1	AmidophosphoribosyltransferaseIBA 12/2020
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 06/2020
1	Aromatase InhibitorsIBA 06/2020
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2018
1	Biomarkers (Surrogate Marker)IBA 09/2018
1	Estrogen ReceptorsIBA 09/2018
1	Proteasome InhibitorsIBA 01/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018
1	UbiquitinIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	Azithromycin (Zithromax)FDA LinkGeneric 04/2016
1	palbociclibIBA 12/2015
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 01/2015
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2015
1	Ointments (Pastes)IBA 01/2015
1	VimentinIBA 01/2015
1	LipidsIBA 05/2014
1	Uric Acid (Urate)IBA 01/2014
1	Orlistat (Xenical)FDA Link 01/2014
1	Atorvastatin (Lipitor)FDA Link 01/2014
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2014
1	Serum AlbuminIBA 01/2014
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2012
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2011
1	Volatile Fatty AcidsIBA 07/2011
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2011
1	Toll-Like Receptor 4IBA 07/2011
1	AzoxymethaneIBA 07/2011
1	SaltsIBA 01/2011
1	Nizatidine (Axid)FDA LinkGeneric 05/2009
1	Proton Pump InhibitorsIBA 05/2009
1	sofalcone (Solon)IBA 05/2009
1	Rabeprazole (Aciphex)FDA Link 05/2009
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2009
1	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 03/2009

Therapy/Procedure

5	Therapeutics 08/2021 - 01/2008
1	Patient Readmission 01/2014
1	Endoscopic Hemostasis 01/2012
1	Drug-Eluting Stents 03/2009